Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]

View source ↗

Summary

Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic malignancies; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Leukemia
• Lymphocytic Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Myeloproliferative Diseases
• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-06-29